CD33 and Alzheimer disease: (89) observed increased circulating CD33+HLA-DR- M-MDSCs and CD33+HLA-DR-CD11b+CD15+ MDSCs in mild cognitive impairment (MCI) patients compared to both AD patients and healthy controls.